HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Validity of the European short list of respiratory diseases: a 40-year autopsy study.

Abstract
The predictors of autopsy and the accuracy of European short list (E) codes of respiratory diseases lack recent knowledge. A 10% random sample (n=6811) of inhabitants of Bergen, Norway, aged 20-70 years, was invited to participate in a survey in 1965-1971 (participation rate 83%). By December 31, 2005, 4387 (64%) participants had died and 1163 (27% of the deceased) had been given an autopsy. Causes of death were tuberculosis (E02, 0.2%), lung malignancy (E15, 3.5%), influenza (E38, 0.2%), pneumonia (E39, 6.5%) and chronic lower respiratory diseases (E40, 3.2%). Male sex, early deaths in the surveillance period and E15 were positive predictors of an autopsy examination, whereas old age and E39 were strong negative predictors. Among those referred for a post mortem examination, the cause of death was verified as tuberculosis in 0.3%, lung cancer in 8.1%, acute pneumonia in 2.0% and chronic obstructive lung diseases in 4.9%. Cohen's kappa coefficients (E codes versus autopsy) were 0.91 (95% CI 0.86-0.96) for E15, 0.37 (95% CI 0.20-0.54) for E39 and 0.65 (95% CI 0.54-0.76) for E40. These findings matter when deaths from respiratory diseases are used as end-points in epidemiological association studies and clinical trials.
AuthorsAnne K Gulsvik, Andreas H Henriksen, Einar Svendsen, Sjur Humerfelt, Amund Gulsvik
JournalThe European respiratory journal (Eur Respir J) Vol. 45 Issue 4 Pg. 953-61 (Apr 2015) ISSN: 1399-3003 [Electronic] England
PMID25359344 (Publication Type: Journal Article, Validation Study)
CopyrightCopyright ©ERS 2015.
Topics
  • Adult
  • Age Factors
  • Aged
  • Autopsy
  • Cause of Death
  • Confidence Intervals
  • Databases, Factual
  • Europe
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mortality (trends)
  • Norway
  • Predictive Value of Tests
  • Respiratory Tract Diseases (diagnosis, mortality, pathology)
  • Retrospective Studies
  • Risk Assessment
  • Sex Factors
  • Urban Population
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: